Podium to Practice: ESMO® 2025 – BREAST: POSITIVE

Explore more from your favourite experts – click their name to access their entire library of content.

Studies / Trials Discussed

LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial

Studies/trials discussed:

LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial